Use of genome-wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high-grade B-cell lymphoma
Journal of Veterinary Internal Medicine · 2024
DOI: 10.1111/jvim.16931 ↗At a glance
Journal article in Journal of Veterinary Internal Medicine, 2024. Written by Yong Bin Teoh and 9 co-authors. Institution: Translational Research Unit, Veterinary Teaching Hospital, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan. Major MEDLINE topics: Lymphoma, B-Cell, Dog Diseases, Sulfites. Cited 1 times so far (Crossref); 38 references. The full text is freely available (open access, CC BY-NC-ND 4.0). Funded by: Anicom Specialty Medical Institute Inc, Tokyo, Japan, Japan Society for the Promotion of Science.
Abstract (original language)
Background
DNA methylation analysis might identify prognostic CpG sites in CHOP-treated dogs with multicentric high-grade B-cell lymphoma (MHGL) with heterogenous prognosis.
Objective
To identify prognostic CpG sites of MHGL through genome-wide DNA methylation analysis with pyrosequencing validation. Animals Test group: 24 dogs. Validation group: 100 dogs. All client-owned dogs were diagnosed with MHGL and treated with CHOP chemotherapy.
Methods
Cohort study. DNA was extracted from lymph node samples obtained via FNA. Genome-wide DNA methylation analysis using Digital Restriction Enzyme Analysis of Methylation (DREAM) was performed on the test group to identify differentially methylated CpG sites (DMCs). Bisulfite pyrosequencing was used to measure methylation status of candidate DMCs in the validation group. Median survival times (MST) were analyzed using Kaplan-Meier (log-rank) product limit method.
Results
DREAM analyzed 101 576 CpG sites. Hierarchical clustering of 16 262 CpG sites in test group identified group with better prognosis (MST = 55-477 days vs 10-301 days, P = .007). Volcano plot identified 1371 differentially methylated CpG sites (DMCs). DMC near the genes of FAM213A (DMC-F) and PHLPP1 (DMC-P) were selected as candidates. Bisulfite-pyrosequencing performed on validation group showed group with methylation level of DMC-F < 40% had favorable prognosis (MST = 11-1072 days vs 8-1792 days, P = .01), whereas group with the methylation level combination of DMC-F < 40% plus DMC-P < 10% had excellent prognosis (MST = 18-1072 days vs 8-1792 days, P = .009). Conclusion and Clinical Importance Methylation status of prognostic CpG sites delineate canine MGHL cases with longer MST, providing owners with information on expectations of potential improved treatment outcomes.
Subjects
MeSH terms (MEDLINE)
Author keywords
Substances
Authors and institutions
- Translational Research Unit, Veterinary Teaching Hospital, Graduate School of Veterinary Medicine, Hokkaido University, Sapporo, Hokkaido, Japan.
- One Health Research Center, Hokkaido University, Sapporo, Hokkaido, Japan.
- North Lab, Sapporo, Hokkaido, Japan.
- Coriell Institute for Medical Research, Camden, New Jersey, USA.
- Anicom Specialty Medical Institute Inc, Tokyo, Japan.
- Laboratory of Veterinary Internal Medicine, University of Tokyo, Tokyo, Japan.
ORCID profiles: Yong Bin Teoh, Hajime Tsujimoto, Mitsuyoshi Takiguchi
Funding
- Anicom Specialty Medical Institute Inc, Tokyo, Japan
- Japan Society for the Promotion of Science
Cite
APA
Teoh, Y. B., Ishizaki, T., Kagawa, Y., Yokoyama, S., Jelinek, J., Matsumoto, Y., Tomiyasu, H., Tsujimoto, H., Takiguchi, M., & Yamazaki, J. (2024). Use of genome-wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high-grade B-cell lymphoma. Journal of Veterinary Internal Medicine. https://doi.org/10.1111/jvim.16931
Vancouver
Teoh YB, Ishizaki T, Kagawa Y, Yokoyama S, Jelinek J, Matsumoto Y, et al. Use of genome-wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high-grade B-cell lymphoma. Journal of Veterinary Internal Medicine. 2024. doi:10.1111/jvim.16931
BibTeX
@article{Teoh2024,
author = {Teoh, Yong Bin and Ishizaki, Teita and Kagawa, Yumiko and Yokoyama, Shoko and Jelinek, Jaroslav and Matsumoto, Yuki and Tomiyasu, Hirotaka and Tsujimoto, Hajime and Takiguchi, Mitsuyoshi and Yamazaki, Jumpei},
title = {Use of genome-wide DNA methylation analysis to identify prognostic CpG site markers associated with longer survival time in dogs with multicentric high-grade B-cell lymphoma},
journal = {Journal of Veterinary Internal Medicine},
year = {2024},
doi = {10.1111/jvim.16931}
}
EUVIMED